Hire an Advanced Robo-Advisor to Trade BDX on Your Behalf.
- Street Sentiment
- Personalized Strategy
- Free Trading Simulator
Course of Action
Sentiment (10 days)
- Strong Buy
- Strong Sell
DAILY PRICE CHANGE VS SENTIMENT
Why Smart Auto-Trading?
Smart Auto-Trading is an advanced robo-advisor designed to provides investors with a trading partner to automate systematic investing. Its robo is designed to screens, monitors and auto-trades elite stocks like BECTON, DICKINSON AND COMPANY (BDX) using artificial intelligence, social media and market data to augments your potential as an investor.
Smart Auto-Trading produces short-term trades which makes it an ideal tool for trading in tax-deferred accounts such as IRA, SIMPLE IRA, Rollover IRA, 529 College Plans, Keoghs and UGMA. If also works in taxable accounts. Just be aware that if you elect to auto-trade using Smart Auto-Trading in a regular brokerage account, you will be taxed at regular income. Make sure you understand your tax situation before using Smart Auto-trading.
Using Smart Auto-Trading is easy. It connects to your brokerage account at Ally Invest, one of the most trusted broker/dealer in the United States. All you need to do is open an account with them, put a minimum of $5,000 in your account and connect Smart Auto-Trading to trade.
There are clear benefits associated with using a robo-advisor such as Smart Auto-Trading to help you reach your financial goals. Smart Auto-Trading simplifies stock investing down to a few steps. It auto-trades for you, using your personalized strategy, while you attend more important life events.
Using Smart Auto-Trading is like having thousands of traders working for you to help you reach your financial goals.
Smart Auto-Trading actively trades which is different from passive investing. The robo is on the lookout working to maximize your potential every business day of the year. It trades on the news taking advantage of price changes and trends by listening into trader's communications and by validating this information with market data.
Smart Auto-Trading is one of the first robo-advisor to take advantage of Government grade listening technology, artificial intelligence, social media and market data natively.
Try Smart Auto-Trading today!
You can test Smart Auto-Trading in simulation mode, risk free, Stock Circles today.
Disclaimer: Past performance may not be indicative of future results. Therefore, you should assume that the future performance of any specific investment, investment strategy (including robo-strategies), or product made in reference directly or indirectly on this website, will be profitable or equal to corresponding indicated performance levels. Robot-Advisors like other investment methods rely on favorable market conditions to provide positive outcomes.
BECTON, DICKINSON AND COMPANY (BDX) News
Marshall Wace LLP Has $4.07 Million Holdings in Becton, Dickinson and Company (BDX)
Marshall Wace LLP grew its holdings in Becton, Dickinson and Company (NYSE:BDX) by 974.0% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 20,879 shares of the medical instruments supplier’s stock after acquiring an additional 18,935 shares during the quarter. Marshall Wace LLP’s holdings in Becton, Dickinson and were worth $4,071,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. Almanack Investment Partners LLC. bought a new stake in shares of Becton, Dickinson and in the first quarter valued at about $105,000. Parkside Financial Bank & Trust boosted its position in shares of Becton, Dickinson and by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 633 shares of the medical instruments supplier’s stock valued at $116,000 after acquiring an additional 9 shares during the period. QCI Asset Management Inc. NY boosted its position in shares of Becton, Dickinson and by 9.2% in the first quarter. QCI Asset Management Inc. NY now owns 710 shares of the medical instruments supplier’s stock valued at $130,000 after acquiring an additional 60 shares during the period. Financial Architects Inc raised its stake in Becton, Dickinson and by 8.0% in the second quarter. Financial Architects Inc now owns 731 shares of the medical instruments supplier’s stock valued at $142,000 after purchasing an additional 54 shares in the last quarter. Finally, Guardian Life Insurance Co. of America raised its stake in Becton, Dickinson and by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 819 shares of the medical instruments supplier’s stock valued at $150,000 after purchasing an additional 6 shares in the last quarter. 87.12% of the stock is owned by institutional investors.
In other news, insider Ellen R. Strahlman sold 9,283 shares of Becton, Dickinson and stock in a transaction dated Thursday, August 10th. The stock was sold at an average price of $198.21, for a total transaction of $1,839,983.43. Following the completion of the sale, the insider now owns 26,638 shares in the company, valued at approximately $5,279,917.98. The sale was disclosed in a filing with the SEC. Also, insider Thomas E. Polen, Jr. sold 5,971 shares of the firm’s stock in a transaction dated Wednesday, August 9th. The shares were sold at an average price of $197.41, for a total value of $1,178,735.11. Following the transaction, the insider now directly owns 12,861 shares in the company, valued at $2,538,890.01. The disclosure for this sale can be found here. In the last quarter, insiders have sold 75,904 shares of company stock valued at $15,242,688. Corporate insiders own 1.40% of the company’s stock.
A number of research firms recently commented on BDX. BidaskClub raised Becton, Dickinson and from a “hold” rating to a “buy” rating in a research note on Monday, August 14th. Cowen and Company reaffirmed an “outperform” rating and issued a $230.00 price target (up previously from $200.00) on shares of Becton, Dickinson and in a research note on Monday, July 10th. Barclays PLC reaffirmed an “equal weight” rating and issued a $210.00 price target (up previously from $205.00) on shares of Becton, Dickinson and in a research note on Thursday, August 10th. Zacks Investment Research raised Becton, Dickinson and from a “hold” rating to a “buy” rating and set a $225.00 price target for the company in a research note on Monday, July 17th. Finally, Wells Fargo & Company began coverage on Becton, Dickinson and in a research note on Friday, September 22nd. They issued an “outperform” rating and a $225.00 price target for the company. Five analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $200.93.
Becton, Dickinson and Company (BDX) opened at 194.32 on Wednesday. The firm has a market cap of $44.22 billion, a P/E ratio of 56.28 and a beta of 1.06. Becton, Dickinson and Company has a 52 week low of $161.29 and a 52 week high of $206.63. The firm’s 50-day moving average price is $199.01 and its 200 day moving average price is $191.58.
Becton, Dickinson and (NYSE:BDX) last issued its quarterly earnings results on Thursday, August 3rd. The medical instruments supplier reported $2.46 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.44 by $0.02. The firm had revenue of $3.04 billion during the quarter, compared to the consensus estimate of $3.06 billion. Becton, Dickinson and had a return on equity of 22.53% and a net margin of 6.25%. The company’s revenue for the quarter was down 5.1% on a year-over-year basis. During the same quarter last year, the company posted $2.35 EPS. Equities analysts forecast that Becton, Dickinson and Company will post $9.46 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, September 29th. Stockholders of record on Friday, September 8th will be given a dividend of $0.73 per share. The ex-dividend date is Thursday, September 7th. This represents a $2.92 dividend on an annualized basis and a dividend yield of 1.50%. Becton, Dickinson and’s dividend payout ratio (DPR) is presently 83.43%.Get Started today! - Risk Free